川金诺 reported revenue of ¥2.11B for the period ended 2026-06-30, +21.1% year on year. Net income was ¥0.12B, a 5.8% net margin on a 13.4% gross margin. The largest revenue line is 磷酸 at 51% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.11B | +21.1% |
| Gross profit | ¥0.28B | — |
| Operating income | ¥0.15B | — |
| Net income | ¥0.12B | -34.1% |
| Gross margin | 13.4% | Net margin 5.8% |
| Revenue Q/Q | +13.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 磷酸 | ¥1.09B | 51.4% |
| 饲料级磷酸盐 | ¥0.73B | 34.4% |
| 磷肥 | ¥0.25B | 11.8% |
| 其他 | ¥0.05B | 2.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.83B | 86.6% |
| R&D | ¥0.01B | 0.6% |
| SG&A | ¥0.10B | 4.5% |
| Tax & other | ¥0.02B | 1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥4.81B |
| Total liabilities | ¥1.73B |
| Shareholders' equity | ¥3.08B |
| Equity / assets | 64.0% |
| Operating cash flow | ¥0.10B |
| Capital expenditure | ¥0.13B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | -177% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
名家汇 ・ 苏奥传感 ・ 维宏股份 ・ 新美星 ・ 金冠股份 ・ 雪榕生物 ・ 中亚股份 ・ 恒实科技 ・ 友讯达 ・ 三德科技 ・ 久之洋 ・ 海波重科
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies